Some members of this committee reviewed blinded summary data for all operators in Massachusetts in the review year. Such data include risk-standardized in-hospital all-cause mortality rates (SMIR), operator volume, operator complication rates, and operator infection rates. For operators identified as having statistically significant higher than expected mortality, unblinded case fatality reports are also reviewed. Other members of the committee reviewed and updated Compassionate Use criteria. Selection of Committee members is the responsibility of the current Governor of the Massachusetts Chapter of the ACC. Committee members are drawn from the pool of operators who have participated in the Mass-DAC chart audit review within two years of the first meeting of the committee in the given review year.

Cliff Berger, M.D.

Interventional Cardiologist
Good Samaritan Medical Center, Brockton, MA

Gregory Giugliano, M.D.

Interventional Cardiologist
Baystate Medical Center, Springfield, MA

Joseph Hannan, M.D.

Interventional Cardiologist
Saint Vincent Hospital, Worcester, MA

Kalon Ho, M.D. MSc

Director of Quality Assurance
Cardiovascular Division
Beth Israel Deaconess Medical Center, Boston, MA

Zoran Nedeljkovic, M.D.

Interventional Cardiologist
Boston Medical Center, Boston, MA

Sharon-Lise Normand

Mass-DAC Liaison
Professor of Health Care Policy (Biostatistics)
Harvard Medical School, Boston, MA

Thomas Piemonte, M.D.

Director, Cardiac Catheterization Laboratory
Lahey Clinc, Burlington, MA

Frederic S. Resnic, M.D. MSc

Director, Cardiac Catheterization Laboratory
Brigham and Women's Hospital, Boston, MA

Kenneth Rosenfield , M.D.

Interventional Cardiologist
Massachusetts General Hospital, Boston, MA

Paul Schwerdt , M.D.

Interventional Cardiologist
Norwood Hospital, Norwood, MA

Samuel J. Shubrooks Jr., M.D.

Interventional Cardiologist
Beth Israel Deaconess Medical Center, Boston, MA